MIF
AZN icon

Mediolanum International Funds’s AstraZeneca AZN Stock Holding History

Mediolanum International Funds’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.3M Buy
+487,420
New +$91.7M 0.79% 25
2025
Q1 		– Sell
-56,502
Closed -$7.39M – 429
2024
Q4 		$7.39M Sell
56,502
-118,545
-68% -$16.6M 0.1% 190
2024
Q3 		$49M Buy
175,047
+139,493
+392% +$22.5M 0.68% 23
2024
Q2 		$5.19M Buy
+35,554
New +$5.35M 0.08% 216

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mediolanum International Funds's AZN Position: Q2 2026 in Review

Mediolanum International Funds opened a new position in AstraZeneca (AZN) in Q2 2026: 487,420 shares worth $92.3M. The stake represents 0.79% of the portfolio and ranks #25 among its holdings. This is a return to the name: Mediolanum International Funds previously reported a position in AZN as recently as Q4 2024.

Mediolanum International Funds first reported a position in AZN in Q2 2024 and has held it in 4 quarters since. 507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Mediolanum International Funds held 487,420 shares of AstraZeneca worth $92.3M as of Q2 2026.
  • AstraZeneca was a new Mediolanum International Funds position in Q2 2026.
  • AstraZeneca made up 0.79% of Mediolanum International Funds's portfolio in Q2 2026, its #25 holding.
  • Mediolanum International Funds first reported a position in AstraZeneca in Q2 2024 and has held it in 4 quarters since.
  • 507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.